Symrise Sees 2025 Results Hurt by Terpenes Deal, Pet-Care Stake

Market Intelligence Analysis

AI-Powered
Why This Matters

Symrise AG expects its 2025 results to be negatively impacted by the sale of its terpene ingredients division and a decrease in the value of its pet-care stake.

Market Impact

Market impact analysis based on bearish sentiment with 80% confidence.

Sentiment
Bearish
AI Confidence
80%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

Symrise AG said a plan to sell its terpene ingredients division and a reduction in the value of its stake in a pet-care business will likely curtail earnings for this year.

Continue Reading
Full article on Bloomberg
Read Full Article
Original article published by Bloomberg on January 12, 2026.
Analysis and insights provided by AnalystMarkets AI.